Reactivation of infectious simian virus 40 from normal human tissues

Journal of NeuroVirology

Volumn 10, Issue 3, 2004, Pages 199-205

  Barbanti Brodano, Giuseppe ^a   Martini, Fernanda ^a   Corallini, Alfredo ^a   Lazzarin, Lorena ^a   Trabanelli, Cecilia ^a   Vignocchi, Beatrice ^a   Calza, Nilla ^a   Iaccheri, Laura ^a   Morelli, Cristina ^a   Tognon, Mauro ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Human DNA; Rescue; SV40; Transfection

Indexed keywords

OLIGONUCLEOTIDE; VIRUS DNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RISK; MONKEY; MONONUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEXUAL TRANSMISSION; SIMIAN VIRUS 40; VERO CELL; VIRUS ISOLATION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS STRAIN; VIRUS TRANSMISSION; VULVA;

ANIMALS; DNA PROBES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; SIMIAN VIRUS 40; TRANSFECTION; TUMOR VIRUS INFECTIONS; VULVA;

SIMIAE; SIMIAN VIRUS 40;

EID: 3042850646     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280490441112     Document Type: Article

References (26)

1. Agostini HT, Yanagihara R, Davis V, Ryschkewitsch CF, Stoner GL (1997). Asian genotypes of JC virus in Native Americans and in a Pacific Island population: markers of viral evolution and human migration. Proc Natl Acad Sci U S A 94: 14542-14546.
2. Barbanti-Brodano G, Martini F, De Mattei M, Lazzarin L, Corallini A, Tognon M (1998). BK and JC human polyomaviruses and simian virus 40: natural history of infection in humans, experimental oncogenicity and association with human tumors. Adv Virus Res 50: 69-99.
3. Barbanti-Brodano G, Sabbioni S, Martini F, Corallini A, Tognon M (2004). Simian Virus 40 infection in humans and association with human diseases: results and hypotheses. Virology 318: 1-8.
4. Basetse HR, Lecatsas G, Gerber LJ (2002). An investigation of the occurrence of SV40 antibodies in South Africa. S Afr Med J 92: 825-828.
5. Bright RK, Kimchi ET, Shearer MH, Kennedy RC, Pass HI (2002). SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients. Cancer Immunol Immunother 50: 682-690.
6. Butel JS, Lednicky JA (1999). Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst 91: 119-134.
7. Dolcetti R, Martini F, Quaia M, Gloghini A, Vignocchi B, Cariati R, Martinelli M, Carbone A, Boiocchi M, Tognon M (2003). Simian virus 40 sequences in human lymphoblastoid B-cell lines. J Virol 77: 1595-1597.
8. Ferber D (2002). Public health. Creeping consensus on SV40 and polio vaccine. Science 298: 725-727.
9. Garcea RL, Imperiale MJ (2003). Simian virus 40 infection of humans. J Virol 77: 5039-5045.
10. Geissler E, Konzer P, Scherneck S, Zimmerman W (1985). Sera collected before introduction of contaminated polio vaccine contain antibodies against SV40. Acta Virol 29: 420-423.
11. Huang KC, Yamasaki EF, Snapka RM (1999). Maintenance of episomal SV40 genomes in GM637 human fibroblasts. Virology 262: 457-469.
12. Jafar S, Rodriguez-Barradas M, Graham DY, Butel JS (1998). Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J Med Virol 54: 276-284.
13. Jasani B, Cristaudo A, Emri SA, Gazdar AF, Gibbs A, Krynska B, Miller C, Mutti L, Radu C, Tognon M, Procopio A (2001). Association of SV40 with human tumors. Semin Cancer Biol 11: 49-61.
14. Lednicky JA, Garcea RL, Bergsagel DJ, Butel JS (1995). Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology 212: 710-717.
15. Lednicky JA, Butel JS (1997). A coupled PCR and restriction digest method for the detection and analysis of the SV40 regulatory region in infected-cell lysates and clinical samples. J Virol Methods 64: 1-9.
16. Li RM, Branton MH, Tanawattanacharoen S, Falk RA, Jennette JC, Kopp JB (2002a). Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J Am Soc Nephrol 13: 2320-2330.
17. Li RM, Mannon RB, Kleiner D, Tsokos M, Bynum M, Kirk AD, Kopp JB (2002b). BK virus and SV40 co-infection in polyomavirus nephropathy. Transplantation 74: 1497-1504.
18. Martini F, De Mattei M, Iaccheri L, Lazzarin L, Barbanti-Brodano G, Gerosa M, Tognon M (1995). Human brain tumors and simian virus 40. J Natl Cancer Inst 87: 1331.
19. Martini F, Dolcetti R, Gloghini A, Iaccheri L, Carbone A, Boiocchi M, Tognon M (1998). Simian-virus-40 footprints in human lymphoproliferative disorders of HIV- and HIV+ patients. Int J Cancer 78: 669-674.
20. Martini F, Iaccheri L, Lazzarin L, Corallini A, Gerosa M, Iuzzolino P, Barbanti-Brodano G, Tognon M (1996). Simian virus 40 early region and large T antigen in human brain tumors, peripheral blood cells and sperm fluids from healthy individuals. Cancer Res 56: 4820-4825.
21. Martini F, Lazzarin L, Iaccheri L, Vignocchi B, Finocchiaro G, Magnani I, Serra M, Scotlandi K, Barbanti-Brodano G, Tognon M (2002). Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors. Cancer 94: 1037-1048.
22. Minor PD, Dunn G, Pipkin PA (2001). Detection and growth kinetics of SV40 preparations with different enhancer element copy number. Vaccine 19: 3467-3471.
23. Pacini F, Vivaldi A, Santoro M, Fedele M, Fusco A, Romei C, Basolo F, Pinchera A (1998). Simian virus 40-like DNA sequences in human papillary thyroid carcinomas. Oncogene 16: 659-665.
24. Rizzo P, Di Resta I, Powers A, Ratner H, Carbone M (1999). Unique strains of SV40 in commercial poliovaccines from 1955 not readily identifiable with current testing for SV40 infection. Cancer Res 59: 6103-6108.
25. Sangar D, Pipkin PA, Wood DJ, Minor PD (1999). Examination of poliovirus vaccine preparations for SV40 sequences. Biologicals 27: 1-10.
26. Strickler HD, Rosenberg PS, Devesa SS, Hertel J, Fraumeni JF, Goedert JJ (1998). Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA 279: 292-295.